SCHEMBL8091245

SCHEMBL8091245

CCOCCS(=O)(=O)NC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 8/20 0.46
MEN1 O00255 6/20 0.46
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
CNR1 P21554 1/20 0.43
MAPT P10636 3/20 0.43
HTT P42858 2/20 0.43
RAB9A P51151 1/20 0.43
NLRP1 Q9C000 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091423 0.84 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL8083314 0.82 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL8091363 0.81 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL8091373 0.80 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1CA12CA1
SCHEMBL8097633 0.74 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL6464101 0.73 SAE1 (0.55) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL8083371 0.73 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL11221363 0.73 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL8097740 0.72 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL8091307 0.72 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US claimed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP claimed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP claimed
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed